1.Molecular docking of epidermal growth factor receptor tyramine kinase domain and its inhibitor genistein.
Jianglan YUAN ; Hui LIU ; Xu KANG ; Guolin ZOU
Chinese Journal of Biotechnology 2008;24(10):1813-1817
Genistein is a high specific and noncompetitive inhibitor of epidermal growth factor receptor tyramine kinase domain (EGFR-TK). In the paper, a molecular docking between genistein and EGFR-TK was studied to explore the mechanism of their interaction and antitumor mechanism of genistein by AUTODOCK 3.05 program. The results indicated that genistein located in the active cavity of EGFR-TK by high affinity (deltaG = -31.2 kJ/mol), and genistein inhibited EGFR-TK by interfering with forming of Lys721/Glu738 ion pair. The inhibition belonged to noncompetitive interaction, in which hydrophobic force and hydrogen bond played key roles.
Catalytic Domain
;
Genistein
;
metabolism
;
pharmacology
;
Models, Molecular
;
Receptor, Epidermal Growth Factor
;
antagonists & inhibitors
;
metabolism
2.Using distance comparison method to build pharmacophore model of epidermal growth factor receptor inhibitors.
Yan-shen GUO ; Feng-ming CHU ; Zong-ru GUO
Acta Academiae Medicinae Sinicae 2004;26(4):379-384
OBJECTIVETo build 3D-pharmacophore model of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors using distance comparisons method and design novel EGFR inhibitors.
METHODSThirteen typical EGFR inhibitors were selected, and their biologically active conformations were obtained by using DOCK5.0 program, then 3D-pharmacophore model of EGFR inhibitors was built using distance comparisons method.
RESULTSValidation of the 3D-pharmacophore model was carried out and novel structures with potential inhibitory activity were selected by means of 3D-searching and docking method.
CONCLUSIONThis method can improve hit rate of lead compounds discovery and can be used to design novel EGFR inhibitors.
Drug Design ; Enzyme Inhibitors ; Epidermal Growth Factor ; metabolism ; Models, Chemical ; Protein-Tyrosine Kinases ; antagonists & inhibitors ; chemistry ; pharmacology ; Receptor, Epidermal Growth Factor ; antagonists & inhibitors ; chemistry ; Structure-Activity Relationship
3.Establishment of homogeneous time-resolved fluorescence immunoassay for high throughput screening of protein tyrosine kinase inhibitors.
Xu-gui LI ; Guang-fa WANG ; Jun-yan ZHANG ; Shao-yu WU ; Wei XU ; Shu-guang WU ; Jia-jie ZHANG
Journal of Southern Medical University 2009;29(8):1612-1614
OBJECTIVETo establish an in vitro homogeneous time-resolved fluorescence immunoassay method for high throughput screening of protein tyrosine kinase (PTK) inhibitors.
METHODSSpecific fluorescence signals at 670 and 612 nm were measured by multifunctional microplate reader when the fluorescence was emitted through a resonance energy transfer between fluorescent materials (EuK and XL-665). The inhibitory activity of Sunitinib, a standard PTK inhibitor, on vascular endothelia growth factor receptor 2 (VEGFR-2) kinase activity was investigated.
RESULTSA homogeneous time-resolved fluorescence immunoassay was established for high throughput screening of PTK inhibitor. In this system, the concentrations of VEGFR-2, adenosine triphosphate (ATP) and poly-peptide substrate were 5 ng/microl, 100 micromol/L and 1 micromol/L, respectively. Sunitinib inhibited VEGFR-2 kinase activity with an IC50 value of 86.7 nmol/L, which was close to the values tested using other methods.
CONCLUSIONThe homogeneous time-resolved fluorescence immunoassay we established can be easily used for high throughput screening of PTK inhibitors.
Fluoroimmunoassay ; methods ; High-Throughput Screening Assays ; methods ; Indoles ; pharmacology ; Peptides ; metabolism ; Phosphorylation ; drug effects ; Protein Kinase Inhibitors ; pharmacology ; Protein-Tyrosine Kinases ; antagonists & inhibitors ; metabolism ; Pyrroles ; pharmacology ; Time Factors ; Vascular Endothelial Growth Factor Receptor-2 ; antagonists & inhibitors ; metabolism
4.Effects of COX-2 inhibitor celecoxib on expressions of VEGF, b-FGF and TGF-β mRNA in acute leukemia cells.
Yan-Fang ZHANG ; Lin-Hai RUAN ; Xiao-Qiang ZHAO
Journal of Experimental Hematology 2012;20(5):1086-1089
This study was aimed to investigate the influence and significance of celecoxib (specific inhibitor of cyclooxygenase-2) on mRNA expressions of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (b-FGF), transforming growth factor β (TGF-β) in acute leukemia cells. The expressions of VEGF, b-FGF, TGF-β mRNA were measured by RT-PCR in acute leukemia cells treated with celecoxib (80 µmol/L, for 48 h) or with PBS. The results showed that the obvious expressions of VEGF, b-FGF, TGF-β mRNA were observed in acute leukemia cells. By using Pearson correlation analysis, there was positive correlation between VEGF mRNA and b-FGF mRNA expressions (r = 0.559, P = 0.001), and negative correlation between VEGF and TGF-β mRNA expressions (r = -0.4, P = 0.029). Expression levels of VEGF, b-FGF, TGF-β mRNA in experimental group were lower than that in control group (P < 0.01). It is concluded that COX-2 inhibitor celecoxib can inhabit vascular endothelial growth through down-regulating the mRNA expression of VEGF, b-FGF and TGF-β in acute leukemia cells. COX-2 inhibitor may offer supplemental effect for treating acute leukemia.
Adult
;
Celecoxib
;
Cyclooxygenase 2 Inhibitors
;
pharmacology
;
Female
;
Fibroblast Growth Factor 2
;
metabolism
;
Humans
;
Leukemia
;
drug therapy
;
metabolism
;
Male
;
Pyrazoles
;
pharmacology
;
RNA, Messenger
;
genetics
;
Signal Transduction
;
Sulfonamides
;
pharmacology
;
Transforming Growth Factor beta
;
metabolism
;
Vascular Endothelial Growth Factor A
;
metabolism
5.Progress of study on inhibitory effects of traditional Chinese herbs on growth factor induced proliferation of vascular smooth muscle cells.
Guang YANG ; Min-zhou ZHANG ; Wei JIANG
Chinese Journal of Integrated Traditional and Western Medicine 2005;25(10):951-954
This paper sums up some studies in the last decade regarding the inhibitory effects of traditional Chinese herbs on growth factor induced proliferation of vascular smooth muscle cell (VSMC) via directly measuring the mRNA expression of its growth factors and the related receptors by electron microscope, immunohistochemistry, blot and hybridization in situ.
Cell Proliferation
;
drug effects
;
Cells, Cultured
;
Drugs, Chinese Herbal
;
pharmacology
;
Fibroblast Growth Factor 2
;
antagonists & inhibitors
;
Humans
;
Muscle, Smooth, Vascular
;
cytology
;
metabolism
;
Platelet-Derived Growth Factor
;
antagonists & inhibitors
6.Analysis of transforming growth factor β signaling in chronic rhinosinusitis.
Yun-Chuan LI ; Yun-Song AN ; Tong WANG ; Hong-Rui ZANG
Chinese Medical Journal 2013;126(17):3340-3343
BACKGROUNDIt has been reported that there is a significant difference in the local tissue concentration of transforming growth factor (TGF)-β1 between chronic rhinosinusitis without nasal polyps (CRSsNP) and chronic rhinosinusitis without nasal polyps (CRSwNP) patients. TGF-β has been reported to play an important role in regulating epithelial cell repair in lower airway remodeling and may be a critical factor involved in the remodeling process of chronic rhinosinusitis (CRS).
METHODSEthmoidal mucosal samples collected from CRS and healthy control patients were analyzed for TGF-β1, TGF-β receptor I, TGF-β receptor II, Smad3, phospho-Smad3, Smad7, and Smad anchor for receptor activation by Western blotting analysis. The proliferation of sinonasal epithelial cells at baseline and after TGF-β1 and/or EGF stimulation was evaluated by the MTT assay.
RESULTSIn CRSsNP, TGF-β1, TGF-β receptor I, TGF-β receptor II, and Smad3 protein levels were significantly higher than controls. In CRSwNP, TGF-β1, Smad3, and pSmad3 protein levels were significantly lower than controls. Smad7 protein was significantly higher in CRS than controls. In vitro experiments demonstrated that the baseline proliferation levels of sinonasal epithelial cells were lower in CRS than controls.
CONCLUSIONSCRSwNP is characterized by a lower level of TGF-signaling compared with the control. In CRSsNP, although the upstream signaling of TGF-β was enhanced, the high Smad7 protein expression may restrain the downstream signaling components (e.g., pSmad3) and the TGF-β antiproliferative effect on sinonasal epithelium. The difference in the local tissue concentration of TGF-β1 between CRSsNP and CRSwNP patients did not result in significant differences in epithelial proliferation.
Adult ; Aged ; Benzamides ; pharmacology ; Cells, Cultured ; Dioxoles ; pharmacology ; Female ; Humans ; Intracellular Signaling Peptides and Proteins ; metabolism ; Male ; Middle Aged ; Protein-Serine-Threonine Kinases ; antagonists & inhibitors ; metabolism ; Receptors, Transforming Growth Factor beta ; antagonists & inhibitors ; metabolism ; Serine Endopeptidases ; metabolism ; Signal Transduction ; drug effects ; Sinusitis ; metabolism ; Smad3 Protein ; metabolism ; Smad7 Protein ; metabolism ; Transforming Growth Factor beta ; metabolism ; Transforming Growth Factor beta1 ; antagonists & inhibitors ; metabolism ; Young Adult
7.Advances of vasculogenic mimicry in tumors.
Chinese Journal of Pathology 2007;36(10):694-697
Angiogenesis Inhibitors
;
pharmacology
;
Angiostatins
;
pharmacology
;
Animals
;
Antigens, CD
;
metabolism
;
Cadherins
;
metabolism
;
Humans
;
Matrix Metalloproteinase Inhibitors
;
Matrix Metalloproteinases
;
metabolism
;
Microvessels
;
metabolism
;
Neoplasms
;
blood supply
;
pathology
;
Neovascularization, Pathologic
;
metabolism
;
pathology
;
Vascular Endothelial Growth Factor A
;
metabolism
8.Screening for inhibitor of vascular endothelial growth factor from random peptide library.
Jie WU ; Hongbin ZHANG ; Jie WANG ; Taicheng YANG ; Jiang XIAN ; Chuanhong YANG ; Wenling ZHENG ; Huipeng CHEN ; Qingming WANG
Chinese Journal of Oncology 2002;24(6):540-543
OBJECTIVETo screen for the inhibitor of vascular endothelial growth factor (VEGF) 165 from random peptide library.
METHODSPositive phage clones were rescued after two rounds of panning and competitive elution. Its affinity activity to KDR was monitored through ELISA, immunohistochemical method, Chicken CAM assay and MTT.
RESULTSFive specific binding positive target molecule phage clones were obtained which were able to bind to cells whose surface had high KDR, among which, clone 3 and 13 could effectively block the vascularization of the chorioallantoic membrane of chick embryo, but they were not inhibitive on the proliferation of high KDR expression cells.
CONCLUSIONThe peptides, being the inhibitors of VEGF, may be useful in the treatment of cancers.
Animals ; Binding Sites ; Endothelial Growth Factors ; antagonists & inhibitors ; metabolism ; Enzyme-Linked Immunosorbent Assay ; Humans ; Intercellular Signaling Peptides and Proteins ; metabolism ; Lymphokines ; antagonists & inhibitors ; metabolism ; Peptide Library ; Peptides ; pharmacology ; Vascular Endothelial Growth Factor A ; Vascular Endothelial Growth Factors
9.Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Kang Jin JEONG ; Soon Young PARK ; Ji Hye SEO ; Kyung Bok LEE ; Wahn Soo CHOI ; Jeung Whan HAN ; Jae Ku KANG ; Chang Gyo PARK ; Yong Kee KIM ; Hoi Young LEE
Experimental & Molecular Medicine 2008;40(6):607-616
Lysophosphatidic acid (LPA) is a bioactive phospholipids and involves in various cellular events, including tumor cell migration. In the present study, we investigated LPA receptor and its transactivation to EGFR for cyclooxygenase-2 (COX-2) expression and cell migration in CAOV-3 ovarian cancer cells. LPA induced COX-2 expression in a dose-dependent manner, and pretreatment of the cells with pharmacological inhibitors of Gi (pertussis toxin), Src (PP2), EGF receptor (EGFR) (AG1478), ERK (PD98059) significantly inhibited LPA- induced COX-2 expression. Consistent to these results, transfection of the cells with selective Src siRNA attenuated COX-2 expression by LPA. LPA stimulated CAOV-3 cell migration that was abrogated by pharmacological inhibitors and antibody of EP2. Higher expression of LPA2 mRNA was observed in CAOV-3 cells, and transfection of the cells with a selective LPA2 siRNA significantly inhibited LPA-induced activation of EGFR and ERK, as well as COX-2 expression. Importantly, LPA2 siRNA also blocked LPA-induced ovarian cancer cell migration. Collectively, our results clearly show the significance of LPA2 and Gi/Src pathway for LPA-induced COX-2 expression and cell migration that could be a promising drug target for ovarian cancer cell metastasis.
Butadienes/pharmacology
;
Cell Line, Tumor
;
Cell Movement/drug effects/*physiology
;
Cyclooxygenase 2/*biosynthesis
;
Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors/metabolism
;
Female
;
Flavonoids/pharmacology
;
GTP-Binding Protein alpha Subunits, Gi-Go/antagonists & inhibitors/*metabolism
;
Humans
;
Lysophospholipids/pharmacology
;
Nitriles/pharmacology
;
Ovarian Neoplasms/metabolism/*pathology
;
Pertussis Toxin/pharmacology
;
Protein-Tyrosine Kinases/antagonists & inhibitors/*metabolism
;
Proto-Oncogene Proteins/antagonists & inhibitors/*metabolism
;
Pyrimidines/pharmacology
;
Receptor, Epidermal Growth Factor/antagonists & inhibitors/metabolism
;
Receptors, Lysophosphatidic Acid/*metabolism
;
Receptors, Prostaglandin E/metabolism
;
Signal Transduction
;
Transcriptional Activation
;
Tyrphostins/pharmacology
10.Inhibitory Effect of EGCG on angiogenesis induced by multiple myeloma cell line KM3 and its mechanism.
Jing SHAO ; Zhi-Chao CHEN ; Qiu-Bai LI ; Jian LÜ
Journal of Experimental Hematology 2007;15(5):973-977
The aim of this study was to investigate the effect of [(-)-epigallocatechin-3-gallate (EGCG)] on angiogenesis induced by multiple myeloma cell line KM3 and its mechanism. The effects of KM3 cell supernatant after being treated with EGCG in different concentrations on migration and vascular formation ability of endothelial cell line HUVEC were investigated through culture of MM cell line KM3 in vitro. The secretion level of vascular endothelial growth factor (VEGF) in KM3 cell supernatant and the expression level of VEGF mRNA in KM3 were detected by ELISA and RT-PCR respectively. The results indicated that the KM3 cell supernatant significantly induced endothelial cell migration and vascular formation in vitro. EGCG inhibited the effect of endothelial cell migration induced by KM3 cell supernatant, and the numbers of migrated cells were 414 +/- 27, 299 +/- 70, 202 +/- 42 and 116 +/- 13 at 5, 25, 50, 100 micromol/L respectively. The numbers of migrated cells showed negative correlation with the dose of EGCG (r = -0.952, p < 0.05). The areas of the capillary-like structures decreased while the concentrations of EGCG increased, 88343.9 +/- 3231.1 microm(2) at 25 micromol/L, 60897.5 +/- 914.1 microm2 at 50 micromol/L, which were significantly less than that in the control (p < 0.01) and showed negative correlation with the dose of EGCG (r = -0.888, p < 0.05). 48 hours after treatment with EGCG at concentrations of 5, 25, 50 and 100 micromol/L, the levels of VEGF in the culture supernatant were 1399.0 +/- 47.4, 660.1 +/- 5.7, 108.5 +/- 5.8 and 26.2 +/- 18.6 pg/ml respectively. Except 5 micromol/L, all the other groups showed significant changes while compared with the controls (p < 0.01). Furthermore, EGCG depressed the mRNA expression of VEGF in KM3 cells in a dose-dependent manner. It is concluded that the EGCG can significantly inhibit angiogenic ability of multiple myeloma KM3 cells, its pharmacological mechanism may be downregulation of VEGF mRNA expression and reduction of VEGF secretion.
Angiogenesis Inhibitors
;
pharmacology
;
Catechin
;
analogs & derivatives
;
pharmacology
;
Cell Line, Tumor
;
Down-Regulation
;
Humans
;
Multiple Myeloma
;
blood supply
;
metabolism
;
RNA, Messenger
;
metabolism
;
Vascular Endothelial Growth Factor A
;
metabolism